#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14220	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2187	646.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1813	1813	T	775	T	716	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14220	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2187	646.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1547	1547	C	889	C	830	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14220	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2187	646.5	0	HET	.	.	.	C923T	.	923	923	C	1286	1286	C	848	C,T	612,183	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26270	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3710	706.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1707	1707	A	934	A,G,C	891,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26270	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3710	706.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2341	2341	C	792	C	743	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26270	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3710	706.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2415	2415	A	763	A	724	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26270	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3710	706.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2967	2967	C	751	C,T,A	700,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2150	folP	855	855	100.0	folP.l15.c4.ctg.1	1503	142.4	1	SNP	p	R229S	1	.	.	685	687	AGC	963	965	AGC	209;208;209	A;G;C	196;198;197	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5852	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3425	170.4	1	SNP	p	S91F	1	.	.	271	273	TTC	609	611	TTC	202;204;205	T;T;C,T	192;195;192,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5852	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3425	170.4	1	SNP	p	D95G	1	.	.	283	285	GGC	621	623	GGC	204;206;207	G;G;C	191;193;193	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5852	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3425	170.4	1	SNP	p	G95N	0	.	.	283	285	GGC	621	623	GGC	204;206;207	G;G;C	191;193;193	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1698	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1327	127.4	1	SNP	p	G45D	0	.	.	133	135	GGC	464	466	GGC	197;200;201	G;G;C,T	186;184;187,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	892	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	950	92.8	0	.	n	.	0	A197.	DEL	197	197	A	504	504	A	208	A	194	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4876	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2845	170.5	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1469	1471	GTC	242;242;242	G;T;C	222;222;222	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4876	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2845	170.5	1	SNP	p	D86N	0	.	.	256	258	GAC	575	577	GAC	182;181;180	G;A;C	175;173;173	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4876	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2845	170.5	1	SNP	p	R87W	0	.	.	259	261	CGT	578	580	CGT	179;181;180	C;G;T	173;175;171	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4876	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2845	170.5	1	SNP	p	S87R	1	.	.	259	261	CGT	578	580	CGT	179;181;180	C;G;T	173;175;171	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4876	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2845	170.5	1	SNP	p	R87I	0	.	.	259	261	CGT	578	580	CGT	179;181;180	C;G;T	173;175;171	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4876	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2845	170.5	1	SNP	p	S88P	0	.	.	262	264	TCC	581	583	TCC	181;182;186	T;C;C	173;175;175	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4376	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2779	156.8	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1366	1368	TGC	208;208;209	T;G,T;C,T	199;195,1;197,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4376	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2779	156.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1576	1578	GGC	205;204;205	G;G;C	192;191;192	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1215	1217	GCA	207;207;205	G;C;A	197;198;199	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1218	1220	ATC	205;205;208	A;T;C,A	197;197;197,1	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1230	1232	GTG	210;210;210	G;T;G	197;196;199	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1230	1232	GTG	210;210;210	G;T;G	197;196;199	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1734	1736	ACC	194;192;190	A,G;C;C	172,1;178;176	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1788	1790	GCG	187;187;183	G;C;G	170;153;158	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1788	1790	GCG	187;187;183	G;C;G	170;153;158	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1911	1913	GGC	177;178;179	G;G;C	167;169;168	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1920	1922	GGC	168;168;171	G;G,T;C	160;159,1;161	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3958	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2458	160.4	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1938	1940	TCG	155;156;153	T,G;C;G	102,8;125;128	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5514	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3060	179.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1605	1607	CCG	202;203;205	C;C;G	177;186;180	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2394	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1778	133.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	472	472	C	151	C	140	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	429	431	GAA	234;233;234	G;A;A	223;223;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	717	719	GAT	215;215;216	G;A;T	203;201;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	840	842	TCA	219;216;215	T;C;A	204;202;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	969	971	GTC	203;201;200	G,C;T;C	184,1;186;184	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	0	.	p	.	0	F222L	NONSYN	664	666	TTT	981	983	CTT	203;203;207	C,T;T;T	193,1;194;198	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1299	1301	GCA	221;223;227	G;C;A	211;213;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	1	SNP	p	G120K	1	.	.	358	360	AAG	675	677	AAG	207;205;206	A;A;G	198;198;197	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	1	SNP	p	A121D	1	.	.	361	363	GAC	678	680	GAC	204;200;197	G;A;C	193;191;189	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2702	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1509	177.2	1	SNP	p	D121N	0	.	.	361	363	GAC	678	680	GAC	204;200;197	G;A;C	193;191;189	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10276	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4930	207.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1986	1988	AAT	234;235;237	A;A;T	220;222;224	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1074	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1132	94.4	1	SNP	p	V57M	1	.	.	169	171	ATG	543	545	ATG	212;212;213	A;T;G	201;201;201	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
